Gilead Sciences, Inc. (GILD) shareholders
Close on Nov 17, 2026Market cap $211.18BP/E –Yield 1.86%
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 101,739,273 | 8.20% | 13G (passive) amendment | Mar 31, 2025 |
| Vanguard Capital Management | 93,327,127 | 7.51% | 13G (passive) | Mar 31, 2026 |
| FMR LLC Joint filing with Abigail P. Johnson (5.30%) | 65,539,477 | 5.30% | 13G (passive) | Dec 31, 2025 |
| Gilead Sciences, Inc. | 18,759,465 | 19.40% | 13G (passive) amendment | Dec 20, 2023 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of GILD | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 121,844,108 | 9.82% | $15.39B | +2,833,135 | 0.23% |
| Vanguard Capital Management LLC | 81,091,734 | 6.54% | $10.25B | +436,958 | 0.22% |
| FMR LLC | 66,870,816 | 5.39% | $8.45B | −5,035,474 | 0.37% |
| State Street Corp | 61,216,552 | 4.94% | $7.73B | +1,357,967 | 0.23% |
| Capital World Investors | 40,988,975 | 3.30% | $5.18B | −294,958 | 0.61% |
| Invesco Ltd. | 39,819,151 | 3.21% | $5.03B | −1,761,672 | 0.40% |
| Vanguard Portfolio Management LLC | 35,316,168 | 2.85% | $4.46B | +186,703 | 0.20% |
| Geode Capital Management, LLC | 30,065,642 | 2.42% | $3.80B | +339,590 | 0.20% |
| Price T Rowe Associates Inc /Md/ | 29,996,694 | 2.42% | $3.79B | +3,748,586 | 0.38% |
| Morgan Stanley | 24,004,354 | 1.94% | $3.03B | +705,059 | 0.16% |
| Dodge & Cox | 23,677,567 | 1.91% | $2.99B | −573,259 | 1.57% |
| Norges Bank | 21,965,555 | 1.77% | $2.78B | New | 0.28% |
| JPMorgan Chase & Co | 20,820,621 | 1.68% | $2.63B | −13,171,789 | 0.15% |
| Capital Research Global Investors | 19,393,296 | 1.56% | $2.45B | −7,734,237 | 0.34% |
| Bank Of America Corp /De/ | 18,649,065 | 1.50% | $2.36B | −1,329,871 | 0.15% |
| Bank of New York Mellon Corp | 15,263,929 | 1.23% | $1.93B | +210,778 | 0.32% |
| Northern Trust Corp | 13,828,010 | 1.11% | $1.75B | +7,631 | 0.20% |
| UBS Asset Management Americas Inc | 12,986,591 | 1.05% | $1.64B | −212,512 | 0.30% |
| Wellington Management Group Llp | 12,699,683 | 1.02% | $1.60B | −838,308 | 0.28% |
| Goldman Sachs Group Inc | 10,778,294 | 0.87% | $1.36B | −286,920 | 0.12% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2,274 | 1.11B | 89.8% | 152 / 952 | 855 / 164 | 89M | 61M |
| Q1 2026 | 2,325 | 1.09B | 87.8% | 247 / 859 | 897 / 106 | 182M | 93M |
| Q4 2025 | 2,219 | 1.12B | 90.6% | 334 / 879 | 742 / 111 | 130M | 81M |
| Q3 2025 | 2,033 | 1.08B | 86.9% | 166 / 832 | 728 / 126 | 68M | 70M |
| Q2 2025 | 2,026 | 1.08B | 87.2% | 188 / 844 | 732 / 153 | 92M | 73M |
| Q1 2025 | 2,018 | 1.06B | 85.8% | 279 / 690 | 831 / 112 | 91M | 84M |
| Q4 2024 | 1,889 | 1.07B | 85.9% | 291 / 656 | 719 / 94 | 80M | 62M |
| Q3 2024 | 1,722 | 1.05B | 84.7% | 173 / 630 | 697 / 115 | 190M | 63M |
| Q2 2024 | 1,681 | 1.05B | 84.3% | 129 / 650 | 690 / 150 | 58M | 93M |
| Q1 2024 | 1,723 | 1.08B | 87.4% | 139 / 637 | 737 / 170 | 80M | 66M |
| Q4 2023 | 1,779 | 1.07B | 86.4% | 224 / 654 | 696 / 100 | 71M | 39M |
| Q3 2023 | 1,685 | 1.04B | 84.0% | 130 / 686 | 634 / 126 | 38M | 33M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
1,360 funds held GILD in Q2 2026, 40% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of GILD | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 39,416,893 | 3.18% | $4.98B | 0.22% | Jun 30, 2026 |
| Vanguard 500 Index Fund | 32,173,750 | 2.59% | $4.06B | 0.24% | Jun 30, 2026 |
| Invesco QQQ Trust, Series 1 | 26,355,038 | 2.12% | $3.33B | 0.68% | Jun 30, 2026 |
| Dodge & Cox Stock Fund | 17,282,812 | 1.39% | $2.18B | 1.84% | Jun 30, 2026 |
| iShares Core S&P 500 ETF | 17,078,628 | 1.38% | $2.16B | 0.24% | Jun 30, 2026 |
| Fidelity 500 Index Fund | 15,877,011 | 1.28% | $2.13B | 0.26% | May 31, 2026 |
| Income Fund of America | 15,498,550 | 1.25% | $2.02B | 1.36% | Jul 31, 2026 |
| Vanguard Value Index Fund | 11,816,681 | 0.95% | $1.49B | 0.59% | Jun 30, 2026 |
| Fidelity Contrafund | 11,403,513 | 0.92% | $1.44B | 0.80% | Jun 30, 2026 |
| Washington Mutual Investors Fund | 10,310,727 | 0.83% | $1.34B | 0.62% | Jul 31, 2026 |
| American Balanced Fund | 9,637,660 | 0.78% | $1.22B | 0.42% | Jun 30, 2026 |
| State Street(R) Health Care Select Sector SPDR(R) ETF | 8,771,312 | 0.71% | $1.11B | 2.73% | Jun 30, 2026 |
| Capital Income Builder | 8,051,806 | 0.65% | $1.05B | 0.80% | Jul 31, 2026 |
| Vanguard Dividend Appreciation Index Fund | 7,024,740 | 0.57% | $914.69M | 0.70% | Jul 31, 2026 |
| Vanguard Institutional Index Fund | 6,740,120 | 0.54% | $851.55M | 0.24% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Daniel Patrick O'Day | Chairman & CEO, Director | 551,683 | 0.04% | Nov 6, 2026 |
| Wettan Keeley M. Cain | EVP Gen Counsel, Legal & Comp | 5,360 | 0.00% | Nov 9, 2026 |
| Andrew D. Dickinson | Chief Financial Officer | 161,096 | 0.01% | Oct 16, 2026 |
| Johanna Mercier | Chief Comm & Corp Aff Officer | 113,684 | 0.01% | Oct 16, 2026 |
| Erin Burkhart | SVP, Controllership | 2,223 | 0.00% | Sep 23, 2026 |
| Dietmar Berger | Chief Medical Officer | 19,785 | 0.00% | Sep 11, 2026 |
| Deborah H. Telman | EVP, Corporate Affairs & GC | 79,641 | 0.01% | Nov 13, 2025 |
| Diane E. Wilfong | Interim Corp Controller & CAO | 46,597 | 0.00% | Sep 11, 2025 |
| Sandra Patterson | SVP, Controllership | 40,077 | 0.00% | Mar 12, 2025 |
| Merdad Parsey | Chief Medical Officer | 84,621 | 0.01% | Dec 11, 2024 |
| Kelly A. Kramer | Director | 1,339 | 0.00% | Nov 16, 2026 |
| Anthony Welters | Director | 20,612 | 0.00% | Aug 27, 2026 |
| Jeffrey Bluestone | Director | 10,066 | 0.00% | Aug 21, 2026 |
| Jacqueline K. Barton | Director | 27,202 | 0.00% | May 4, 2026 |
| Javier Rodriguez | Director | 13,364 | 0.00% | May 4, 2026 |
| Sandra Horning | Director | 6,293 | 0.00% | May 4, 2026 |
| Ted W. Love | Director | 5,484 | 0.00% | May 4, 2026 |
| Harish Manwani | Director | 15,015 | 0.00% | May 4, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Kelly A. Kramer Director | Nov 12, 2026 | Sale(10b5-1 plan) | −200 | $171.44 | $34.29K | 1,339 |
| Kelly A. Kramer Director | Nov 12, 2026 | Sale(10b5-1 plan) | −4,700 | $170.49 | $801.32K | 1,539 |
| Kelly A. Kramer Director | Nov 12, 2026 | Sale(10b5-1 plan) | −3,800 | $169.44 | $643.88K | 6,239 |
| Kelly A. Kramer Director | Nov 12, 2026 | Sale(10b5-1 plan) | −1,676 | $168.23 | $281.95K | 10,039 |
| Kelly A. Kramer Director | Nov 12, 2026 | Option exercise | +10,376 | $66.92 | $694.36K | 11,715 |
| Wettan Keeley M. Cain EVP Gen Counsel, Legal & Comp | Nov 6, 2026 | Sale(10b5-1 plan) | −3,399 | $164.11 | $557.81K | 5,360 |
| Daniel Patrick O'Day Chairman & CEO, Director | Nov 5, 2026 | Sale(10b5-1 plan) | −9,810 | $175.17 | $1.72M | 551,683 |
| Daniel Patrick O'Day Chairman & CEO, Director | Nov 5, 2026 | Option exercise | +9,810 | $72.34 | $709.66K | 561,493 |
| Daniel Patrick O'Day Chairman & CEO, Director | Nov 4, 2026 | Sale(10b5-1 plan) | −102,619 | $175.16 | $17.98M | 551,683 |
| Daniel Patrick O'Day Chairman & CEO, Director | Nov 4, 2026 | Option exercise | +102,619 | $72.34 | $7.42M | 654,302 |
| Daniel Patrick O'Day Chairman & CEO, Director | Nov 2, 2026 | Sale(10b5-1 plan) | −2,000 | $171.06 | $342.13K | 551,683 |
| Daniel Patrick O'Day Chairman & CEO, Director | Nov 2, 2026 | Sale(10b5-1 plan) | −7,796 | $170.35 | $1.33M | 553,683 |
| Daniel Patrick O'Day Chairman & CEO, Director | Nov 2, 2026 | Sale(10b5-1 plan) | −1,904 | $169.27 | $322.30K | 561,479 |
| Daniel Patrick O'Day Chairman & CEO, Director | Nov 2, 2026 | Sale(10b5-1 plan) | −1,700 | $168.10 | $285.77K | 563,383 |
| Daniel Patrick O'Day Chairman & CEO, Director | Nov 2, 2026 | Sale(10b5-1 plan) | −1,600 | $167.40 | $267.84K | 565,083 |
| Daniel Patrick O'Day Chairman & CEO, Director | Oct 30, 2026 | Sale(10b5-1 plan) | −15,881 | $175.25 | $2.78M | 566,683 |
| Daniel Patrick O'Day Chairman & CEO, Director | Oct 30, 2026 | Option exercise | +15,881 | $72.34 | $1.15M | 582,564 |
| Johanna Mercier Chief Comm & Corp Aff Officer | Oct 15, 2026 | Sale(10b5-1 plan) | −3,000 | $156.22 | $468.66K | 113,684 |
| Andrew D. Dickinson Chief Financial Officer | Oct 15, 2026 | Sale(10b5-1 plan) | −3,000 | $156.22 | $468.66K | 161,096 |
| Daniel Patrick O'Day Chairman & CEO, Director | Oct 1, 2026 | Sale(10b5-1 plan) | −3,000 | $148.63 | $445.88K | 566,683 |
| Daniel Patrick O'Day Chairman & CEO, Director | Oct 1, 2026 | Sale(10b5-1 plan) | −12,000 | $147.72 | $1.77M | 569,683 |
| Erin Burkhart SVP, Controllership | Sep 22, 2026 | Option exercise | +2,223 | – | – | 2,223 |
| Erin Burkhart SVP, Controllership | Sep 22, 2026 | Tax withholding | −768 | $152.67 | $117.25K | 1,455 |
| Johanna Mercier Chief Comm & Corp Aff Officer | Sep 15, 2026 | Sale(10b5-1 plan) | −600 | $145.29 | $87.17K | 116,684 |
| Johanna Mercier Chief Comm & Corp Aff Officer | Sep 15, 2026 | Sale(10b5-1 plan) | −800 | $144.46 | $115.57K | 117,284 |
| Johanna Mercier Chief Comm & Corp Aff Officer | Sep 15, 2026 | Sale(10b5-1 plan) | −1,600 | $143.69 | $229.90K | 118,084 |
| Andrew D. Dickinson Chief Financial Officer | Sep 15, 2026 | Sale(10b5-1 plan) | −3,000 | $145.29 | $435.87K | 164,096 |
| Dietmar Berger Chief Medical Officer | Sep 10, 2026 | Option exercise | +533 | – | – | 19,785 |
| Dietmar Berger Chief Medical Officer | Sep 10, 2026 | Tax withholding | −263 | $144.81 | $38.09K | 19,522 |
| Daniel Patrick O'Day Chairman & CEO, Director | Sep 10, 2026 | Option exercise | +8,780 | – | – | 585,913 |
| Daniel Patrick O'Day Chairman & CEO, Director | Sep 10, 2026 | Tax withholding | −4,230 | $144.81 | $612.55K | 581,683 |
| Wettan Keeley M. Cain EVP Gen Counsel, Legal & Comp | Sep 10, 2026 | Tax withholding | −285 | $144.81 | $41.27K | 8,759 |
| Wettan Keeley M. Cain EVP Gen Counsel, Legal & Comp | Sep 10, 2026 | Option exercise | +590 | – | – | 9,044 |
| Andrew D. Dickinson Chief Financial Officer | Sep 10, 2026 | Option exercise | +2,797 | – | – | 168,443 |
| Andrew D. Dickinson Chief Financial Officer | Sep 10, 2026 | Tax withholding | −1,347 | $144.81 | $195.06K | 167,096 |
| Johanna Mercier Chief Comm & Corp Aff Officer | Sep 10, 2026 | Tax withholding | −1,347 | $144.81 | $195.06K | 119,684 |
| Johanna Mercier Chief Comm & Corp Aff Officer | Sep 10, 2026 | Option exercise | +2,797 | – | – | 121,031 |
| Daniel Patrick O'Day Chairman & CEO, Director | Sep 1, 2026 | Sale(10b5-1 plan) | −5,408 | $149.38 | $807.85K | 577,133 |
| Daniel Patrick O'Day Chairman & CEO, Director | Sep 1, 2026 | Sale(10b5-1 plan) | −7,992 | $148.36 | $1.19M | 582,541 |
| Daniel Patrick O'Day Chairman & CEO, Director | Sep 1, 2026 | Sale(10b5-1 plan) | −1,600 | $147.51 | $236.02K | 590,533 |
| Anthony Welters Director | Aug 26, 2026 | Option exercise | +7,718 | $60.67 | $468.25K | 20,612 |
| Anthony Welters Director | Aug 26, 2026 | Option exercise | +10,282 | $61.35 | $630.80K | 23,176 |
| Anthony Welters Director | Aug 26, 2026 | Sale(10b5-1 plan) | −3,118 | $148.31 | $462.43K | 17,494 |
| Anthony Welters Director | Aug 26, 2026 | Sale(10b5-1 plan) | −3,402 | $148.24 | $504.31K | 19,774 |
| Anthony Welters Director | Aug 26, 2026 | Sale(10b5-1 plan) | −6,880 | $148.82 | $1.02M | 12,894 |
| Anthony Welters Director | Aug 26, 2026 | Sale(10b5-1 plan) | −4,600 | $148.82 | $684.57K | 12,894 |
| Jeffrey Bluestone Director | Aug 20, 2026 | Sale(10b5-1 plan) | −26 | $146.36 | $3.81K | 10,066 |
| Jeffrey Bluestone Director | Aug 20, 2026 | Option exercise | +335 | $61.35 | $20.55K | 10,401 |
| Jeffrey Bluestone Director | Aug 20, 2026 | Sale(10b5-1 plan) | −335 | $146.26 | $49.00K | 10,066 |
| Jeffrey Bluestone Director | Aug 20, 2026 | Option exercise | +1,816 | $67.45 | $122.49K | 11,882 |
| Jeffrey Bluestone Director | Aug 20, 2026 | Sale(10b5-1 plan) | −1,165 | $143.75 | $167.47K | 10,066 |
| Jeffrey Bluestone Director | Aug 20, 2026 | Option exercise | +1,165 | $67.45 | $78.58K | 11,231 |
| Jeffrey Bluestone Director | Aug 20, 2026 | Sale(10b5-1 plan) | −1,816 | $144.92 | $263.17K | 10,066 |
| Jeffrey Bluestone Director | Aug 20, 2026 | Option exercise | +26 | $67.45 | $1.75K | 10,092 |
| Jeffrey Bluestone Director | Aug 20, 2026 | Sale(10b5-1 plan) | −1,658 | $145.73 | $241.62K | 10,066 |
| Jeffrey Bluestone Director | Aug 20, 2026 | Option exercise | +1,658 | $67.45 | $111.83K | 11,724 |
| Johanna Mercier Chief Comm & Corp Aff Officer | Aug 17, 2026 | Option exercise | +23,110 | $66.64 | $1.54M | 144,344 |
| Johanna Mercier Chief Comm & Corp Aff Officer | Aug 17, 2026 | Option exercise | +1,890 | $72.34 | $136.72K | 146,234 |
| Johanna Mercier Chief Comm & Corp Aff Officer | Aug 17, 2026 | Sale(10b5-1 plan) | −16,530 | $137.37 | $2.27M | 129,704 |
| Johanna Mercier Chief Comm & Corp Aff Officer | Aug 17, 2026 | Sale(10b5-1 plan) | −11,470 | $138.04 | $1.58M | 118,234 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Gilead Sciences's stock actually held short. Settlement fails (shares not delivered on time) peaked at 81,355 shares on Oct 9, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Wettan Keeley M. Cain Officer | Nov 6, 2026 | 3,399 | $569.57K | Nov 6, 2026 | Restricted Stock Units |
| Daniel Patrick O'Day Director, Officer | Nov 4, 2026 | 112,429 | $18.83M | Nov 4, 2026 | Exercise of Stock Options |
| Daniel Patrick O'Day Director, Officer | Oct 30, 2026 | 45,881 | $7.60M | Oct 30, 2026 | Exercise of Stock Options |
| Andrew D. Dickinson Officer | Oct 15, 2026 | 3,000 | $468.66K | Oct 15, 2026 | Performance Shares |
| Johanna Mercier Officer | Oct 15, 2026 | 3,000 | $468.66K | Oct 15, 2026 | Performance Shares |
| Andrew D. Dickinson Officer | Sep 15, 2026 | 3,000 | $435.87K | Sep 15, 2026 | Performance Shares |
| Johanna Mercier Officer | Sep 15, 2026 | 3,000 | $432.65K | Sep 15, 2026 | Performance Shares |
| Anthony Welters Director | Aug 26, 2026 | 18,000 | $2.68M | Aug 26, 2026 | Exercise of Stock Options |
| Jeffrey Bluestone Director | Aug 20, 2026 | 5,000 | $738.00K | Aug 20, 2026 | Exercise of Stock Options |
| Johanna Mercier Officer | Aug 17, 2026 | 28,000 | $3.85M | Aug 17, 2026 | Stock Option Exercise |
| Andrew D. Dickinson Officer | Aug 17, 2026 | 3,000 | $415.08K | Aug 17, 2026 | Performance Shares |
| Daniel Patrick O'Day Director, Officer | Aug 3, 2026 | 55,000 | $7.16M | Aug 3, 2026 | Restricted Stock Units and Performance Stock Units |
| Andrew D. Dickinson Officer | Jul 15, 2026 | 3,000 | $389.78K | Jul 15, 2026 | Performance Shares |
| Johanna Mercier Officer | Jul 15, 2026 | 3,000 | $389.76K | Jul 15, 2026 | Performance Shares |
| Johanna Mercier Officer | Jun 15, 2026 | 3,000 | $371.76K | Jun 15, 2026 | Performance Shares |
Congress trades
40 trades in Gilead Sciences reported by 19 members of the House
| Member | Type | Traded | Amount | Filed |
|---|---|---|---|---|
| Jared Moskowitz FL23 | Bought | May 6, 2026 | $1K–15K | Jun 19, 2026 |
| Jared Moskowitz FL23 · child | Bought | May 6, 2026 | $1K–15K | Jun 19, 2026 |
| Josh Gottheimer NJ05 · joint account | Bought | Jan 27, 2026 | $1K–15K | Feb 26, 2026 |
| Valerie Hoyle OR04 · spouse | Sold | Sep 23, 2025 | $1K–15K | Oct 10, 2025 |
| Marjorie Taylor Greene GA14 | Bought | Jun 6, 2025 | $1K–15K | Jun 18, 2025 |
| Josh Gottheimer NJ05 · joint account | Sold | May 14, 2025 | $1K–15K | Jun 11, 2025 |
| Jefferson Shreve IN06 | Sold | May 12, 2025 | $15K–50K | Jun 22, 2025 |
| Marjorie Taylor Greene GA14 | Bought | May 5, 2025 | $1K–15K | May 6, 2025 |
| Marjorie Taylor Greene GA14 | Bought | May 5, 2025 | $1K–15K | May 6, 2025 |
| Jefferson Shreve IN06 | Bought | Mar 31, 2025 | $15K–50K | Apr 11, 2025 |
| Carol Devine Miller WV01 | Bought | Mar 10, 2025 | $1K–15K | Apr 11, 2025 |
| Josh Gottheimer NJ05 · joint account | Bought | Mar 7, 2025 | $1K–15K | Apr 10, 2025 |
| Marjorie Taylor Mrs Greene GA14 | Bought | Dec 24, 2024 | $1K–15K | Dec 27, 2024 |
| Valerie Hoyle OR04 · spouse | Bought | Oct 29, 2024 | $1K–15K | Sep 12, 2025 318 days late |
| Greg Stanton AZ04 · spouse | Sold | Oct 24, 2023 | $1K–15K | Nov 9, 2023 |
| Greg Stanton AZ04 · spouse | Bought | Sep 26, 2023 | $1K–15K | Nov 9, 2023 |
| Daniel Goldman NY10 | Sold | Jul 12, 2023 | $15K–50K | Aug 13, 2023 |
| Zoe Lofgren CA18 · spouse | Sold | May 25, 2023 | $1K–15K | Jun 6, 2023 |
| Daniel Goldman NY10 | Bought | Mar 6, 2023 | $15K–50K | Apr 17, 2023 |
| Zoe Lofgren CA18 · spouse | Bought | Sep 9, 2022 | $1K–15K | Oct 11, 2022 |
| Carol Devine Miller WV01 · spouse | Sold (part) | Nov 10, 2021 | $15K–50K | Sep 2, 2022 296 days late |
| Sara Jacobs CA51 | Sold | Apr 9, 2021 | $15K | May 28, 2021 49 days late |
| Marjorie Taylor Greene GA14 · joint account | Bought | Jan 21, 2021 | $1K–15K | Feb 19, 2021 |
| Gilbert Cisneros CA31 | Sold | Dec 22, 2020 | $1K–15K | Jan 11, 2021 |
| Dean Phillips MN03 | Sold (part) | Dec 18, 2020 | $1K–15K | Jan 9, 2021 |
| Dean Phillips MN03 | Bought | Sep 23, 2020 | $1K–15K | Oct 9, 2020 |
| Ed Perlmutter CO07 · spouse | Sold (part) | Sep 1, 2020 | $1K–15K | Nov 11, 2020 71 days late |
| Ed Perlmutter CO07 · spouse | Bought | Jul 15, 2020 | $1K–15K | Sep 29, 2020 76 days late |
| William R. Timmons IV SC04 · spouse | Sold | Jun 29, 2020 | $1K–15K | Aug 7, 2020 |
| Roger W. Marshall KS01 · child | Bought | May 7, 2020 | $1K–15K | Jun 3, 2020 |
| Roger W. Marshall KS01 · child | Bought | May 5, 2020 | $1K–15K | Jun 3, 2020 |
| Roger W. Marshall KS01 · child | Bought | May 4, 2020 | $1K–15K | Jun 3, 2020 |
| Gilbert Cisneros CA31 | Bought | Mar 18, 2020 | $1K–15K | Apr 16, 2020 |
| Mikie Sherrill NJ11 | Sold | Feb 20, 2020 | $1K–15K | Apr 5, 2020 |
| Gilbert Cisneros CA31 | Bought | Feb 7, 2020 | $1K–15K | Mar 10, 2020 |
| Mikie Sherrill NJ11 | Bought | Jan 21, 2020 | $1K–15K | Feb 19, 2020 |
| Mikie Sherrill NJ11 | Sold | Dec 18, 2019 | $1K–15K | Jan 10, 2020 |
| Earl Blumenauer OR03 | Bought | Oct 25, 2019 | $1K–15K | Nov 13, 2019 |
| Bill Flores TX17 | Bought | Sep 19, 2019 | $1K–15K | Oct 7, 2019 |
| Dean Phillips MN03 | Sold (part) | May 13, 2019 | $1K–15K | Jun 13, 2019 |
See a number that looks wrong?